RNAimmune
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
401 Professional Dr Ste 280, Gaithersbur...Phone Number
(240) 702-2233Website
www.rnaimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RNAimmune
RNAimmune, founded in 2020 in Gaithersburg, Maryland, is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The Company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. RNAimmune is a spin-off venture from Sirnaomics, Inc. and has received a global exclusive right to the proprietary Polypeptide Lipid Nanoparticle (PLNP) technology for mRNA delivery from Sirnaomics. The Company has also developed a proprietary A.I. algorithm (ALEPVA) for antigen prediction and vaccine design. By integrating multiple established platform technologies, RNAimmune is aiming to develop a comprehensive mRNA drug discovery and development platform, from which the Company will enrich its therapeutic and vaccine product pipeline addressing tremendous unmet needs in treatments of viral infections, cancer and rare diseases.Explore more
RNAimmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RNAimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RNAimmune has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if RNAimmune is spiking on competitors!
Funding: Get notified immidiatlly once RNAimmune has new funding data
RNAimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if RNAimmune had a recent Job posting/layoffs
Product Launch: Get notified when RNAimmune launches new products
Earning: See what the market has to say on RNAimmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at RNAimmune
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to RNAimmune
Compare insights from companies similar to RNAimmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RNAimmune is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RNAimmune is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RNAimmune.
RNAimmune financials insights
Gather financial insights about RNAimmune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$2.4M
2021
Angel/Seed
$10M
2022
Series A
$27M
RNAimmune Tech Stack
A closer look at the technologies used by RNAimmune
Most Recent Scoops
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Funding
Funding
Funding
RNAimmune News & Media
Innoforce's Partner RNAimmune Granted IND Clearance for RSV mRNA Vaccine from FDA
HANGZHOU, China, Dec. 18, 2023 /PRNewswire/ -- RNAimmune, Inc., a partner of Innoforce, announced the U.S. Food and Drug Administration (FDA) granted IND clearance for its RV-1770 Respiratory Syncytial Virus (RSV) mRNA vaccine. Innoforce congratulates RNAimmune on this significant...Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology WorkstationDrug Product Filled with Berkshire Sterile’s Low Loss Fill Process Receives FDA Greenlight
Lee, MA, May 18, 2023 (GLOBE NEWSWIRE) -- RNAimmune, a biotech company focused on developing groundbreaking mRNA therapies, recently received FDA approval to begin Phase 1 clinical studies for an investigational new drug (IND). The drug product was supplied by Berkshire Sterile Manufacturing, using their new low-loss fill process. The process was key to overcoming product sensitivity challenges and reducing drug product loss to supply product for clinical studies in time.RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine
GERMANTOWN, Md. and GUANGZHOU, China, April 27, 2023 /PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding RNAimmune
Sign Up For FreeTo access detailed company insights
RNAimmune, founded in 2020 in Gaithersburg, Maryland, is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The Company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. RNAimmune is a spin-off ve... Read More
